For research laboratory use only
But heres the thing we havent touched on: some research finds that a B12 deficiency can also result in weight gain
not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile
This enhancement makes PRP+ particularly effective for treating chronic inflammatory conditions and injuries to joints, tendons, and ligaments
BPC-157 takes the opposite approach by supporting tissue integrity while reducing inflammatory signaling
Like BPC-157, it is not FDA-approved, and we are transparent about that distinction